Items where authors include "Mostafid, H"

Article

Hafeez, S, Webster, A, Hansen, VN et al. (17 more authors) (2020) Protocol for tumour-focused dose-escalated adaptive radiotherapy for the radical treatment of bladder cancer in a multicentre phase II randomised controlled trial (RAIDER): radiotherapy planning and delivery guidance. BMJ Open, 10 (12). ARTN e0410. ISSN 2044-6055

Witjes, JA, Babjuk, M, Bellmunt, J et al. (119 more authors) (2020) Corrigendum to ‘EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines Committees’ [European Urology 77 (2020) 223–250]. European Urology, 78 (1). e48-e50. ISSN 0302-2838

Witjes, JA, Babjuk, M, Bellmunt, J et al. (118 more authors) (2020) EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort†: Under the Auspices of the EAU-ESMO Guidelines Committees. European Urology, 77 (2). pp. 223-250. ISSN 0302-2838

Horwich, A, Babjuk, M, Bellmunt, J et al. (118 more authors) (2019) EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees. Annals of Oncology, 30 (11). pp. 1697-1727. ISSN 0923-7534

Tan, WS, Sarpong, R, Khetrapal, P et al. (16 more authors) (2019) Does urinary cytology have a role in haematuria investigations? BJU International, 123 (1). pp. 74-81. ISSN 1464-4096

Simpson, GR, Horvath, A, Annels, NE et al. (10 more authors) (2012) Combination of a fusogenic glycoprotein, pro-drug activation and oncolytic HSV as an intravesical therapy for superficial bladder cancer. British Journal of Cancer, 106. pp. 496-507. ISSN 0007-0920